An early clinical trial of lenperone (AHR 2277), a butyrophenone, in chronic schizophrenia.
D000374:Aggression; D000704:Analysis of Variance; D001145:Arrhythmias, Cardiac / Q000139:chemically induced; D001480:Basal Ganglia Diseases / Q000139:chemically induced; D001565:Benzoates / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D002090:Butyrophenones / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D004305:Dose-Response Relationship, Drug; D006236:Handwriting; D006801:Humans; D008297:Male; D010880:Piperidines / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D010919:Placebos; D011569:Psychiatric Status Rating Scales; D012559:Schizophrenia / Q000188:drug therapy*; D013223:Statistics as Topic; D014149:Tranquilizing Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D014202:Tremor / Q000139:chemically induced
D001565:Benzoates; D002090:Butyrophenones; D010880:Piperidines; D010919:Placebos; D014149:Tranquilizing Agents